CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access Webinar CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access CertaraJanuary 14, 2026
Transform PK/PD workflows with automation and integration Blog Transform PK/PD workflows with automation and integration Reduce delays and errors in PK/PD workflows. See where workflows stall, from data prep to…CertaraJanuary 14, 2026
Phoenix® PK/PD Software now Includes Generative AI pharmacokinetic (PK) Reports Announcement Phoenix® PK/PD Software now Includes Generative AI pharmacokinetic (PK) Reports New module transforms tables, figures and listings into draft PK reports saving scientists weeks of…CertaraJanuary 12, 2026
Efficient creation of Tables, Figures & Listings with Certara’s Phoenix Cloud TFL Studio APAC Webinar On-Demand Webinar Efficient creation of Tables, Figures & Listings with Certara’s Phoenix Cloud TFL Studio APAC Webinar Watch our webinar with Kristin Follman to discover how TFL Studio streamlines the process to…CertaraJanuary 5, 2026
Evaluation of a New Formulation That Improves the Bioavailability and Food Effect of Abiraterone: An Open-Label, Crossover, Randomized, Controlled, Phase I Clinical Trial Publication Evaluation of a New Formulation That Improves the Bioavailability and Food Effect of Abiraterone: An Open-Label, Crossover, Randomized, Controlled, Phase I Clinical Trial Find out how RL001 delivers >1000 mg tablet exposure with reduced food effect and improved…CertaraJanuary 1, 2026
Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained-Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions Publication Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained-Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions Explore how two replicated trials confirm diclofenac SR test and reference tablets are bioequivalent under…CertaraJanuary 1, 2026
Certara Announces New Release of Integral® Software Announcement Certara Announces New Release of Integral® Software Latest version enhances efficiency, compliance, and user experience for PK scientists Radnor, PA. — December…Danielle PillsburyDecember 16, 2025
Pharmacokinetic and bioequivalence of two formulations of Valsartan/Amlodipine Tablet(I) in healthy Chinese volunteers: A randomized, three-period, partially replicated crossover study Publication Pharmacokinetic and bioequivalence of two formulations of Valsartan/Amlodipine Tablet(I) in healthy Chinese volunteers: A randomized, three-period, partially replicated crossover study Discover how randomized crossover study shows new valsartan/amlodipine formulation is bioequivalent to the reference product,…CertaraDecember 13, 2025
Therapeutic drug monitoring of amikacin in Chinese premature infant: a population pharmacokinetic analysis and dosage optimization. Publication Therapeutic drug monitoring of amikacin in Chinese premature infant: a population pharmacokinetic analysis and dosage optimization. See how PopPK modelling in Chinese premature infants identifies key covariates and supports model‑based amikacin…CertaraDecember 6, 2025
PK Report Creation with AI: From Days to Minutes On-Demand Webinar PK Report Creation with AI: From Days to Minutes AI PK Reports, a component of Phoenix Cloud, turns the protocol, data tables and figures…CertaraDecember 4, 2025